Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CLGN

CollPlant Biotechnologies (CLGN)

CollPlant Biotechnologies Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLGN
DateTimeSourceHeadlineSymbolCompany
25/09/202421:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
21/08/202406:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
20/08/202421:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
19/08/202422:34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
19/08/202422:30PR Newswire (US)CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast ImplantsNASDAQ:CLGNCollPlant Biotechnologies Ltd
29/07/202421:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
06/06/202421:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
29/05/202421:28IH Market NewsUS Index Futures Drop Amid Rising Treasury Yields and Inflation Concerns, Oil Prices IncreaseNASDAQ:CLGNCollPlant Biotechnologies Ltd
29/05/202421:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/04/202422:31IH Market NewsUS Index Futures Rise, Oil Dips SlightlyNASDAQ:CLGNCollPlant Biotechnologies Ltd
16/02/202400:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
16/02/202400:00PR Newswire (US)CollPlant Issues Letter to ShareholdersNASDAQ:CLGNCollPlant Biotechnologies Ltd
26/01/202407:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLGNCollPlant Biotechnologies Ltd
02/01/202423:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
29/11/202323:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
01/11/202322:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
11/10/202307:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
22/09/202321:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLGNCollPlant Biotechnologies Ltd
21/09/202321:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
13/09/202302:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLGNCollPlant Biotechnologies Ltd
02/09/202306:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
24/08/202321:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
19/07/202306:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
26/06/202321:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
14/06/202321:34Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CLGNCollPlant Biotechnologies Ltd
24/05/202321:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
19/04/202306:31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLGNCollPlant Biotechnologies Ltd
11/04/202322:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/04/202322:59Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/04/202322:26Business WireStratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and OrgansNASDAQ:CLGNCollPlant Biotechnologies Ltd
 Showing the most relevant articles for your search:NASDAQ:CLGN